X
Software Functionality Revealed in Detail
We’ve opened the hood on every major category of enterprise software. Learn about thousands of features and functions, and how enterprise software really works.
Get free sample report

Compare Software Solutions
Visit the TEC store to compare leading software solutions by funtionality, so that you can make accurate and informed software purchasing decisions.
Compare Now
 

 biotech pharma


Biopharma Contracts and Chargeback Systems: A Peek into the Market
Managing revenues, risk, and compliance is critical to the survival of biotech and pharmaceutical companies (biopharma). But the complexity of revenue

biotech pharma  to the survival of biotech and pharmaceutical companies (biopharma). But the complexity of revenue management in biopharma, such as contract and chargebacks, is not handled by ERP solutions. This article looks at contracts and chargeback systems functionality for biopharma and how that could help companies in other industries effectively manage their revenue streams.

Read More


Software Functionality Revealed in Detail

We’ve opened the hood on every major category of enterprise software. Learn about thousands of features and functions, and how enterprise software really works.

Get free sample report
Compare Software Solutions

Visit the TEC store to compare leading software by functionality, so that you can make accurate and informed software purchasing decisions.

Compare Now

Documents related to » biotech pharma

SaaS Buyer's Guide for Wholesale and Distribution


SaaS, despite its phenomenal popularity, is certainly not one-size-fits-all. You need to consider decision criteria such as fit, return on investment, and risk. Learn how SaaS works, who the major vendors are, how SaaS can help your business grow, and how to find the SaaS solution that’s right for you. It’s all in this comprehensive SaaS Buyer’s Guide for Wholesale and Distribution from TEC and SupplyChainBrain.

biotech pharma   Read More

The Executive Guide to Contract and Chargeback Management


Life sciences companies are struggling to manage large group purchase organization (GPO) contracts, process chargeback submissions, and ensure that pricing policies comply with regulatory requirements. Costs and risks are escalating as these demands outstrip the capabilities of existing systems. Learn how contract and chargeback management solutions can help you maximize growth while limiting regulatory risk.

biotech pharma   Read More

A Portrait of the Enterprise Software User in the Pharmaceutical Industry


The pharmaceutical industry faces strict regulatory requirements in the approval of drugs for treatment of diseases. Software can help pharma successfully manage compliance and risk and quickly bring effective and safe drugs to market. Read this article by TEC product manager Rahim Kaba on the types of software and functional priorities that pharma users seek to streamline their operations and manage regulatory compliance.

biotech pharma   Read More

The State of Global Clinical Research Trials


New technologies and changing economic conditions have triggered a number of changes in the pharmaceuticals, life sciences, and biotech sectors. Increased global sales of life sciences products and growing demand for drugs present drug industry companies with a host of opportunities. However, the mandate for clinical trials has led to considerable inflation in their research and development (R&D) expenditure. The resolution lies in using emerging markets as an alternative to conduct these trials. Thanks to new technologies, the cloud, and social media/online portals, the pharmaceuticals, life sciences and biotech sectors can make the most of the emerging opportunities. Learn how.

biotech pharma   Read More

SYSPRO-Taking a Quantum Leap or Simply Becoming Smarter?


What do Einstein’s theory of relativity and quantum theory have to do with SYSPRO? TEC principal analyst P.J. Jakovljevic explains, as he discusses how SYSPRO has applied these famous physics theories to produce a ‘simply smarter’ ERP system and comprehensive ERP framework for effective material, cash, as well as collaborative management for small to midsized manufacturers and distributors in today’s dynamic environment.

biotech pharma   Read More

SCT Extends Into Business Intelligence


SCT, a leading supplier to the process industries, has extended their iProcess.SCT product set to include Business Intelligence (BI).

biotech pharma   Read More

Not Yet Sold on SaaS ERP in Manufacturing? Take a Hard Look at Plex Online - Part 3


Part 1 of this blog series explained Plex Systems’ ebullience and growth despite a hostile and depressed environment, especially in the discrete manufacturing sector. While the software as a service (SaaS) model is now mainstream in many functional areas of business, the article concurred with Frank Scavo’s recent assertion that, for the time being, there is only one true SaaS enterprise resource

biotech pharma   Read More

Protecting Sensitive Information in Life Sciences Organizations: Top Three Misconceptions that Put Companies at Risk


Critical business processes in biotech and pharmaceutical companies involve highly confidential documents that need to be safely accessed by external partners and potential licensees. Poor security measures, based on a traditional view of data security, have led to high-profile security breaches. Discover new ways for life sciences companies to conduct important business securely without being impeded by IT complexity.

biotech pharma   Read More

Future Trends in Wholesale Distribution—Part 1: Disruptive Innovations


The TEC Vendor Challenge was in full swing last week, with a full slate of vendor demonstrations from Epicor, IBS, Infor, Microsoft, NetSuite, SAP, and VAI, as well as presentations and dynamic discussions. Aberdeen’s Bob Heaney, Pemeco’s Jonathan Gross, and I had a great time at the end of the first day talking about future trends in wholesale distribution.

biotech pharma   Read More

Will 2013 Be IBS’ Comeback Year? Part 1


Several years ago enterprise applications market observers might have talked about Sweden’s “Three I” enterprise resource planning (ERP) vendors: Intentia, IFS, and IBS. While hardly anyone has ever questioned those publicly traded vendors’ industry savvy and product functionality, all three of them have struggled with stagnant growth and red ink for the major part of the late 1990s and early

biotech pharma   Read More